MIR10396B: A Potential Drug Target Or Biomarker (G113218488)
MIR10396B: A Potential Drug Target Or Biomarker
MIR10396B (hsa-miR-10396b-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the miRNA-10396 family, which is known for its role in regulating various cellular processes such as cell growth, apoptosis, and inflammation.
MIR10396B is expressed in a variety of tissues and cells, including brain, heart, liver, and muscle. It has been shown to play a role in regulating cell proliferation and has been associated with the development of various diseases, including cancer.
One of the key functions of MIR10396B is its ability to interact with the protein miR-10396a, which is a miRNA-10396 family member. The miR-10396a protein has been shown to play a negative role in cell proliferation and has been shown to interact with MIR10396B to inhibit its activity.
This interaction between MIR10396B and miR-10396a raises the possibility that MIR10396B could be a drug target or biomarker for the treatment of diseases that are characterized by uncontrolled cell growth, such as cancer.
In addition to its potential as a drug target, MIR10396B has also been shown to have potential as a biomarker for certain diseases. For example, it has been shown to be elevated in the blood of patients with various types of cancer, including breast, lung, and ovarian cancer.
Furthermore, MIR10396B has also been shown to be regulated by various factors, including growth factors, apoptosis, and inflammation. This suggests that it may play a role in the regulation of cellular processes that are important for human health and disease.
Overall, MIR10396B is a promising candidate as a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.
Protein Name: MicroRNA 10396b
The "MIR10396B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR10396B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270
